Research article · 14 Apr 2026
Conference abstractPublished 6 Oct 2017
Development of five hyper-humanized antibodies neutralizing the Botulinum neurotoxins A, B and E: The European AntiBotABE project
Institut de Recherche BiomÃ?©dicale des ArmÃ?©es, France Technische UniversitÃ?¤t Braunschweig, Germany Unit of Anaerobic Bacteria and Toxins and National Reference Center of Anaerobic Bacteria and Botulism, Paris, France National Institute for Biological Standards and Control, United Kingdom University of Helsinki, Finland Biotem, France
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Botulism is a naturally occurring disease, mainly caused by the ingestion of food contaminated by one of the 7 serotypes (A to G) of botulinum neurotoxins (BoNTs). BoNT/A is the most lethal biological substance currently known, with a human 50% lethal dose estimated at 1 ng.kg-1, and they are classified among the 6 major biological warfare agents. AntiBotABE, a European Framework, 7 funded projects aimed to develop 6 humanized IgGs, neutralizing BoNT serotypes A, B and E by targeting their heavy (HC) and light chains (LC). Six macaques were immunized with the recombinant LC or HC of BoNT/A, B or E, and their corresponding immune libraries were generated and screened by phage-display. After each panning, the most reactive scFv were isolated and their affinity measured. Inhibition or neutralization capacities were determined in vitro (SNAP25 or VAMP2 endopeptidasic assay) or ex vivo (mouse phrenic nerve-diaphragm assay). Neutralizing scFvs were identified for 5 of the 6 antigens. For each of the 5 libraries, the most efficient scFv was germline-humanized and expressed as full-length IgG. In the mouse bioassays, 3/5 IgGs alone and all IgGs in pairs, protected mice from paralysis or death after a challenge with the respective BoNT serotype. 1âÂ?Â?5 Antibodies isolated during this project are potential lead candidates for further clinical development and we are looking for clinical development opportunity.
Subjects
Infectious DiseasesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Infectious Diseases & Therapy.
Research article · 5 May 2025
The Ultimate Cure for the COVID Syndemic
Mini review · 29 Apr 2025
COVID-19 Systematic Mini-Review as of April 2025
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Infectious Diseases & Therapy
- SubjectInfectious Diseases
- BylineArticles whose byline prints “Arnaud Avril”
- BylineArticles whose byline prints “Sebastian Miethe”
- BylineArticles whose byline prints “Michel R Popoff”
- BylineArticles whose byline prints “Christelle Mazuet”
- BylineArticles whose byline prints “Christine Rasetti-escargueil”
- BylineArticles whose byline prints “Hannu Korkeala”
- BylineArticles whose byline prints “Dorothea Sesardic”
- BylineArticles whose byline prints “Thibaut Pelat”